Search research articles
Contact Us
Filters
Showing results (171-180 of 236) with videos related to
Page
of 24
Sort By:
Cancer Immunology Research
|
September 26, 2014
Immune activation and a 9-year ongoing complete remission following CD40 antibody therapy and metastasectomy in a patient with metastatic melanoma
David L Bajor, Xiaowei Xu, Drew A Torigian, et al.
Cancer Immunology, Immunotherapy : CII
|
August 28, 2007
Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)
Sylvia Janetzki, Katherine S Panageas, Leah Ben-Porat, et al.
European Journal of Internal Medicine
|
October 23, 2023
One-year outcomes following a hypertensive urgency or emergency
Christos Fragoulis, Dimitrios Polyzos, Andreas Mavroudis, et al.
Clinical and Experimental Pharmacology & Physiology
|
March 1, 2018
Uric acid as an independent predictor of coronary artery disease in essential hypertension: Data from an 8-year-follow-up study
Ioannis Andrikou, Costas Tsioufis, Kyriakos Dimitriadis, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2025
Trastuzumab Deruxtecan Combination Strongly Enhances Responses and Overcomes Sotorasib Resistance in <i>KRAS</i> <sup>G12C</sup> -Mutant NSCLC
Hilal Ozakinci, Bina Desai, Denise Kalos, et al.
Translational Lung Cancer Research
|
May 22, 2026
Pre-clinical efficacy of trastuzumab deruxtecan plus sotorasib in <i>KRAS<sup>G12C</sup></i> -mutant non-small cell lung cancer and exploratory HER2 profiling in human tumors
Hilal Ozakinci, Bina Desai, Denise Kalos, et al.
European Journal of Preventive Cardiology
|
October 31, 2021
Profile and management of hypertensive urgencies and emergencies in the emergency cardiology department of a tertiary hospital: a 12-month registry
Christos Fragoulis, Kyriakos Dimitriadis, Eirini Siafi, et al.
The Journal of Experimental Medicine
|
June 5, 2002
CD8(+) T cell tolerance to a tumor-associated antigen is maintained at the level of expansion rather than effector function
Claes Ohlén, Michael Kalos, Laurence E Cheng, et al.
Blood
|
April 12, 2015
IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients
Michael A Pulsipher, Chris Carlson, Bryan Langholz, et al.
Cancer Immunology Research
|
March 1, 2014
Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies
Gregory L Beatty, Andrew R Haas, Marcela V Maus, et al.
Page
of 24
Search research articles
Search
Showing results (171-180 of 236) with videos related to
Sort By:
Page
of 24
Cancer Immunology Research
|
September 26, 2014
Immune activation and a 9-year ongoing complete remission following CD40 antibody therapy and metastasectomy in a patient with metastatic melanoma
David L Bajor, Xiaowei Xu, Drew A Torigian, et al.
Cancer Immunology, Immunotherapy : CII
|
August 28, 2007
Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)
Sylvia Janetzki, Katherine S Panageas, Leah Ben-Porat, et al.
European Journal of Internal Medicine
|
October 23, 2023
One-year outcomes following a hypertensive urgency or emergency
Christos Fragoulis, Dimitrios Polyzos, Andreas Mavroudis, et al.
Clinical and Experimental Pharmacology & Physiology
|
March 1, 2018
Uric acid as an independent predictor of coronary artery disease in essential hypertension: Data from an 8-year-follow-up study
Ioannis Andrikou, Costas Tsioufis, Kyriakos Dimitriadis, et al.
Biorxiv : the Preprint Server for Biology
|
January 7, 2025
Trastuzumab Deruxtecan Combination Strongly Enhances Responses and Overcomes Sotorasib Resistance in <i>KRAS</i> <sup>G12C</sup> -Mutant NSCLC
Hilal Ozakinci, Bina Desai, Denise Kalos, et al.
Translational Lung Cancer Research
|
May 22, 2026
Pre-clinical efficacy of trastuzumab deruxtecan plus sotorasib in <i>KRAS<sup>G12C</sup></i> -mutant non-small cell lung cancer and exploratory HER2 profiling in human tumors
Hilal Ozakinci, Bina Desai, Denise Kalos, et al.
European Journal of Preventive Cardiology
|
October 31, 2021
Profile and management of hypertensive urgencies and emergencies in the emergency cardiology department of a tertiary hospital: a 12-month registry
Christos Fragoulis, Kyriakos Dimitriadis, Eirini Siafi, et al.
The Journal of Experimental Medicine
|
June 5, 2002
CD8(+) T cell tolerance to a tumor-associated antigen is maintained at the level of expansion rather than effector function
Claes Ohlén, Michael Kalos, Laurence E Cheng, et al.
Blood
|
April 12, 2015
IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients
Michael A Pulsipher, Chris Carlson, Bryan Langholz, et al.
Cancer Immunology Research
|
March 1, 2014
Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce anti-tumor activity in solid malignancies
Gregory L Beatty, Andrew R Haas, Marcela V Maus, et al.
Page
of 24